Transcriptome-based drug repositioning identifies TPCA-1 as a potential selective inhibitor of esophagus squamous carcinoma cell viability

Esophageal squamous cell carcinoma (ESCC) is a cancer type with limited treatment options. The present study aimed to screen for small molecules that may inhibit ESCC cell viability. The small-molecule-perturbed signatures were extrapolated from the library of integrated network-based cellular signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zongyang, Zou, Linjun, Xiao, Zhi-Xiong, Yang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015666/
https://www.ncbi.nlm.nih.gov/pubmed/35417037
http://dx.doi.org/10.3892/ijmm.2022.5131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015666/
https://www.ncbi.nlm.nih.gov/pubmed/35417037
http://dx.doi.org/10.3892/ijmm.2022.5131

Ejemplares similares